Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Understanding investment diversification is essential for any investor. Learn its importance and how it can benefit your portfolio.
28,657 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Alphabet stock looks undervalued as the tech giant rides a fresh wave of AI monetization, beating quarterly targets a...
Robinhood launches a controlled beta of its new Social feature, inviting a small group of users to follow traders, di...
XRP would need a dramatic rally and strong regulatory clarity to reach $20 this cycle. This report weighs the math, t...
Job seekers face mounting anxiety as hiring slows despite a tight labor market, leaving many worried about fit, pay, ...
Parag Agrawal’s startup is launching Index to quantify how AI agents use publisher content and to compensate creators...
The 30-year treasury just crossed 5%, triggering a rotation from growth into asset-backed champions. This article fla...
Qualcomm unveils an edge AI architecture designed to move data center AI power closer to devices. The move could resh...
As markets wobble in 2026, suze orman’s sober advice guides grieving spouses to pause large financial actions for six...
Hycroft Mining and Silvercorp Metals jumped in today's session as gold and silver miners rally on heightened geopolit...
Tensions with Iran push costs beyond official tallies, raising inflation risk and weighing on markets. This report br...
Lululemon is set to report its Q1 results tonight as margins, growth mix, and international exposure take center stag...